300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Retail
Social Impact
SaaS
Cryptocurrency
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Facebook
Gaming
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Hospitality
Legal
eSports
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Theatre
Medical
Infrastructure
Recruiting
Cannabis
Web3
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Music
Wine and Spirits
Food and Beverage
Art
Publishing
Manufacturing
Real Estate
Digital Media
Sporting Goods
FinTech
Finance
Financial Services
Franchise
Mobile Advertising
Social Media
Non Profit
Internet
Android
Sustainability
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
Peru
Slovenia
San Marino
Ukraine
United Kingdom
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Per Samuelsson, Partner at HealthCap

Per Samuelsson

Partner @ HealthCap

Stockholm, Sweden

Per Samuelsson is a Series A investor at HealthCap in Stockholm focused on Medical and Health Care. Per Samuelsson is based out of Stockholm, Stockholms Lan and is the Partner of HealthCap. Per previously worked at ABB Aros Securites as a Director, Corporate Finance. Per Samuelsson attended the The Institute of Technology at Linköping University.

Total investments:
3
Last investment:
Lead investor:
33%

Last updated:

Industries Per Samuelsson invests in

MedicalHealth CareTherapeuticsBiotechnologyPharmaceutical

Stages Per Samuelsson invests in

Series ASeries B

Countries Per Samuelsson invests in

United StatesGermany

Investment Focus

Industry

  • Medical 2 (67%)
  • Health Care 2 (67%)
  • Therapeutics 2 (67%)
  • Biotechnology 2 (67%)
  • Pharmaceutical 1 (33%)

Stage

  • Series A 2 (67%)
  • Series B 1 (33%)

Country

  • United States 2 (67%)
  • Germany 1 (33%)

Investments

CompanyDescriptionRoundLinks
Pretzel Therapeutics Pretzel Therapeutics
Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinatingfeatures that make it unlike any other organelle in the body. $72.5M / Series A / Sep 12, 2022
Ariceum Therapeutics Ariceum Therapeutics
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. $26.8M / Series A / Jun 08, 2022
Nucleonics Nucleonics
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics. $49.2M / Series B / Jun 02, 2004

Co-Investors

HealthCap

About HealthCap

VC Fund · Stockholm, Sweden

HealthCap is a family of multi stage venture capital funds, investing globally in life sciences, with the Odlander Fredrikson Group as their exclusive investments advisor. With committed capital exceeding € 800 million, HealthCap is one of the largest specialized provider of venture capital within life sciences Europe.

HealthCap Contacts

NameEmailPhoneSocials
Bjorn Odlander
Bjorn Odlander Founder and Partner
Marten Steen
Marten Steen Partner
Per Samuelsson
Per Samuelsson Partner
Anki Forsberg
Anki Forsberg Partner
Carl Dalsgaard
Carl Dalsgaard Venture Partner

Sign up to unlock verified contacts

Unlock Contacts
Open HealthCap full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Retail
Social Impact
SaaS
Cryptocurrency
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Facebook
Gaming
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Hospitality
Legal
eSports
Construction
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Theatre
Medical
Infrastructure
Recruiting
Cannabis
Web3
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Music
Wine and Spirits
Food and Beverage
Art
Publishing
Manufacturing
Real Estate
Digital Media
Sporting Goods
FinTech
Finance
Financial Services
Franchise
Mobile Advertising
Social Media
Non Profit
Internet
Android
Sustainability
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
Peru
Slovenia
San Marino
Ukraine
United Kingdom
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Per Samuelsson invest in?

Per Samuelsson invests primarily in Medical, Health Care and Therapeutics startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Per Samuelsson last invest?

The most recent investment recorded for Per Samuelsson closed in Sep 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Per Samuelsson Per Samuelsson Find email